title: Effect of indomethacin on peritoneal protein loss in a rabbit model of peritonitis.
abstract: BACKGROUND
  Although various inflammatory mediators have been previously shown to be released into the peritoneal cavity during peritonitis in peritoneal dialysis patients, those that are involved in governing changes in peritoneal permeability to small solutes and protein remain incompletely defined.
  
  
  METHODS
  We determined the importance of prostanoid production in the enhanced protein loss observed during acute peritonitis by inhibition experiments using indomethacin, an inhibitor of cyclooxygenase activity. The association between changes in peritoneal permeability and the generation of inflammatory mediators after adding Escherichia coli to peritoneal dialysate was first examined in series 1 experiments. Series 2 experiments then determined the effect of intraperitoneal administration of indomethacin (75 microg/mL) on changes in peritoneal permeability after adding E. coli to peritoneal dialysate. All experiments were performed in male New Zealand White rabbits (2.6 to 3.4 kg body weight) using an eight-hour dwell of dialysate containing 2.5% glucose. Peritoneal permeability to creatinine and protein was assessed by time-dependent changes in the dialysate to plasma concentration ratios of these solutes.
  
  
  RESULTS
  Series 1 experiments showed enhanced leukocyte migration into the peritoneal cavity and increased peritoneal permeability to protein during bacterial challenge that was accompanied by an increase in the dialysate concentrations of prostaglandin E2 (PGE2), 6-keto-PGF1alpha, and interleukin-8, but not nitrate + nitrite (a measure of local nitric oxide production). Inhibition of prostanoid production by intraperitoneal administration of indomethacin in series 2 experiments resulted in lower dialysate concentrations of PGE2 and 6-keto-PGF1alpha and in lower peritoneal permeability to protein, both to control levels. No effect of indomethacin on transperitoneal migration of leukocytes or the generation of interleukin-8 was observed.
  
  
  CONCLUSIONS
  Enhanced production of prostanoids likely plays an important role in governing the increase in peritoneal permeability to protein during acute, bacterial peritonitis in the rabbit.
authors.affiliation: Research and Medical Services, Department of Veterans Affairs Medical Center, University of Utah, Salt Lake City, Utah 84112-5350, USA.
authors.forename: H
authors.initials: H
authors.lastname: Peng
authors.forename: A K
authors.initials: AK
authors.lastname: Cheung
authors.forename: L G
authors.initials: LG
authors.lastname: Reimer
authors.forename: C D
authors.initials: CD
authors.lastname: Kamerath
authors.forename: J K
authors.initials: JK
authors.lastname: Leypoldt
mesh_terms: D015121:6-Ketoprostaglandin F1 alpha / Q000032:analysis; D000818:Animals; D002465:Cell Movement / Q000187:drug effects; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology*; D015314:Dialysis Solutions / Q000737:chemistry; D015232:Dinoprostone / Q000032:analysis; D004927:Escherichia coli Infections; D007213:Indomethacin / Q000494:pharmacology*; D007274:Injections, Intraperitoneal; D016209:Interleukin-8 / Q000032:analysis; D007962:Leukocytes / Q000502:physiology; D008297:Male; D010537:Peritoneum / Q000378:metabolism*; D010538:Peritonitis / Q000378:metabolism* / Q000382:microbiology; D011453:Prostaglandins / Q000378:metabolism; D011506:Proteins / Q000378:metabolism*; D011817:Rabbits
chemical_list: D016861:Cyclooxygenase Inhibitors; D015314:Dialysis Solutions; D016209:Interleukin-8; D011453:Prostaglandins; D011506:Proteins; D015121:6-Ketoprostaglandin F1 alpha; D015232:Dinoprostone; D007213:Indomethacin